Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

All NewsSeptember 18, 2025

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott’s Libre 3.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent